About SI-BONE, Inc.
https://si-bone.comSI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.
CEO
Laura A. Francis MBA
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 107
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Truist Securities
Buy
Canaccord Genuity
Buy
Needham
Buy
Citizens Capital Markets
Market Outperform
Morgan Stanley
Overweight
Cantor Fitzgerald
Overweight
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:3.85M
Value:$67.09M
BLACKROCK, INC.
Shares:3.46M
Value:$60.26M
AMERICAN CENTURY COMPANIES INC
Shares:2.84M
Value:$49.5M
Summary
Showing Top 3 of 196
About SI-BONE, Inc.
https://si-bone.comSI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $48.66M ▲ | $44.23M ▼ | $-4.57M ▲ | -9.38% ▲ | $-0.11 ▲ | $-2.41M ▲ |
| Q2-2025 | $48.63M ▲ | $45.81M ▲ | $-6.15M ▲ | -12.65% ▲ | $-0.14 ▲ | $-4.12M ▲ |
| Q1-2025 | $47.29M ▼ | $45.17M ▲ | $-6.54M ▼ | -13.83% ▼ | $-0.15 ▼ | $-4.6M ▼ |
| Q4-2024 | $49M ▲ | $44.27M ▲ | $-4.5M ▲ | -9.17% ▲ | $-0.11 ▲ | $-2.49M ▲ |
| Q3-2024 | $40.34M | $39.54M | $-6.58M | -16.3% | $-0.16 | $-4.61M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $145.74M ▲ | $234.27M ▲ | $62.15M ▲ | $172.13M ▲ |
| Q2-2025 | $145.54M ▲ | $230.92M ▲ | $60.58M ▲ | $170.34M ▲ |
| Q1-2025 | $144.41M ▼ | $227.28M ▼ | $60.02M ▼ | $167.26M ▲ |
| Q4-2024 | $150.04M ▼ | $230.44M ▲ | $63.47M ▲ | $166.96M ▲ |
| Q3-2024 | $150.82M | $227M | $62.02M | $164.97M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-4.57M ▲ | $2.33M ▲ | $-10.03M ▼ | $11K ▼ | $-7.66M ▼ | $-620K ▲ |
| Q2-2025 | $-6.15M ▲ | $173K ▲ | $-9.47M ▼ | $2.23M ▲ | $-7.04M ▼ | $-1.93M ▲ |
| Q1-2025 | $-6.54M ▼ | $-4.91M ▼ | $10.63M ▲ | $103K ▲ | $6.24M ▲ | $-6.98M ▼ |
| Q4-2024 | $-4.5M ▲ | $1.18M ▲ | $4.34M ▲ | $-78K ▼ | $4.72M ▲ | $-1.09M ▲ |
| Q3-2024 | $-6.58M | $302K | $3.77M | $155K | $4.65M | $-2.73M |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $80.00M ▲ | $40.00M ▼ | $50.00M ▲ | $50.00M ▲ |
CEO
Laura A. Francis MBA
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 107
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Truist Securities
Buy
Canaccord Genuity
Buy
Needham
Buy
Citizens Capital Markets
Market Outperform
Morgan Stanley
Overweight
Cantor Fitzgerald
Overweight
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:3.85M
Value:$67.09M
BLACKROCK, INC.
Shares:3.46M
Value:$60.26M
AMERICAN CENTURY COMPANIES INC
Shares:2.84M
Value:$49.5M
Summary
Showing Top 3 of 196